Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

Riffyn Hits Enterprise-grade Compliance and Security Milestones

Riffyn, a global provider of cloud software for scientific process design and data analytics, announced today it has achieved two major compliance-related milestones:

Both accomplishments position Riffyn for routine use in the most demanding high-security and FDA-regulated environments at global enterprises.

"Providing secure, compliant, and uninterrupted business processes for our customers remains our top priority," said Timothy Gardner, CEO and President. "By meeting the highest security standards and regulatory obligations, we help our customers by reducing the barriers to innovation, simplifying the IT landscape, and reducing the costs associated with data integrity and information security."

ISO27001:2013 is one of the most widely recognized and internationally accepted information security standards. To achieve the certification, Riffyn's security compliance was validated by NQA after rigorously demonstrating a systematic and ongoing approach to managing and protecting company and customer data.

Riffyn also announced that it has been validated for GLP/GMP compliant use by a top-10 pharmaceutical company. In doing so, Riffyn demonstrates that it supports the highest quality guidelines for software development, documentation and testing.

"We are extremely proud that we have been recognized and validated for our adherence to FDA and ISO standards," said Gardner. "Riffyn is honored to partner with global leaders and support their goals of inventing medicines, materials, and sustainable biotechnology products for the most challenging needs."

About Riffyn (www.riffyn.com)

Riffyn's pioneering software-as-a-service platform for scientific experimentation solves previously intractable data fragmentation and data sharing problems in R&D organizations. Using patented technology based on "scientific blueprints", Riffyn breaks down data silos to provide deeply integrated data sets for real-time analysis and global access. Riffyn supports eight of the top 15 global biopharmaceutical, biotechnology, and food technology firms.

These press releases may also interest you

at 19:15
The "Global Biostimulants Market (by Active Ingredients, Application & Crop Type): Insights, Trends and Forecast (2019-2023)" report has been added to ResearchAndMarkets.com's offering. The global biostimulants market is expected to reach US$3.97...

at 19:11
TAB GmbH, the mobile performance specialist of the PIA Group with seven locations worldwide, is buying the technology from DCypher Media B.V. and is now offering customers tailor-made product offerings and In-house technology under the new name...

at 19:05
simPRO has announced a partnership with Square to provide fast and simple payment processing options to field service professionals. simPRO is a comprehensive software solution with features to simplify field service management for trade contracting...

at 19:00
The State of Kansas today announced the launch of the Kansas Business One Stop - ksbiz.kansas.gov. The new site is a joint effort by the Secretary of State's office and several state agencies to simplify the process of starting, operating and growing...

at 19:00
Global Access to Cancer Care Foundation (GACCF) http://www.globalaccf.org, the leading global cancer care organization providing oncology education programs in low and middle-income countries (LMICs), announced today a new strategic partnership with...

at 18:20
Insight Enterprises, Inc. (the "Company") today announced that it will release financial results for the quarter ended September 30, 2019 prior to market open on Wednesday, November 6, 2019 and will also host a conference call and live webcast at...

News published on 27 june 2019 at 09:05 and distributed by: